Ansell Limited: Blue-chip stock of the week

There are a number of factors which make Ansell a great stock for long-term investors.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

When it comes to identifying outstanding businesses such as Ansell Limited (ASX: ANN), one of the key factors to consider is a firm's ability to maintain a sustainable competitive advantage which can help to defend its earnings power far into the future.

There are some good reasons to think Ansell meets these criteria. As a manufacturer of fast moving consumer goods (FMCG) Ansell has successfully built strong brand power amongst its customers in a number of regions around the world. This combination of recurring sales, brand names and the ability to be a low cost manufacturer of a value added product is exactly the reason Warren Buffett has often been attracted to the FMCG sector.

Ansell also continues to innovate to keep ahead of competitors. One recent example of this is its licensing agreement with Starpharma Holdings Limited (ASX: SPL) which gives it the exclusive right to sell a value-added product in many regions.

Solid double-digit growth

There are two positives which stand out about Ansell at present. Firstly the company is forecast to grow at a solid rate. In FY 2013 the firm earned 104.2 cents per share (cps), in FY 2014 earnings per share (EPS) are forecast to increase to 115.7 cps, and in FY 2015 to 133.5 cps. In comparison, another high quality blue-chip company Woolworths Limited (ASX: WOW) will struggle to average 5% growth in EPS according to forecasts by Morningstar research.

Appealing valuation

Secondly, the higher growth rate of Ansell could reasonably be expected to result in a higher multiple ascribed to the company's earnings, however based on consensus forecasts for FY 2015, Ansell is trading on a price-to-earnings (PE) multiple of just 14.2. In comparison, Woolworths is trading on 17.6. While a valuation of Ansell does need to take into consideration the lack of franking attached to its earnings and its exposure to foreign currencies which can lead to more volatile earnings, expectations of solid growth makes Ansell's current pricing worthy of close investor attention.

Motley Fool contributor Tim McArthur does not own shares in any of the companies mentioned in this article.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »